
Maharashtra FDA chief targets medical consumable pricing disparities
The story in brief
Maharashtra FDA chief Tukaram Munde proposed guidelines to address excessive price differences and lack of patient information on medical consumables. He highlighted a 2,841% markup on an intravenous infusion set, noting patients often cannot verify if printed prices reflect actual costs. A Maharashtra survey revealed wide gaps between procurement prices and marked-up retail prices.